Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016

被引:26
|
作者
Moro, Pedro [1 ]
Baumblatt, Jane [2 ]
Lewis, Paige [1 ]
Cragan, Janet [3 ]
Tepper, Naomi [4 ]
Cano, Maria [1 ]
机构
[1] Ctr Dis Control & Prevent CDC, Immunizat Safety Off, Div Healthcare Qual Promot, NCEZID, 1600 Clifton Rd,MS D26, Atlanta, GA 30329 USA
[2] US FDA, Div Epidemiol, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res, Silver Spring, MD USA
[3] CDC, Birth Defects Branch, Div Congenital & Dev Disabil, NCBDDD, Atlanta, GA 30333 USA
[4] CDC, Womens Hlth & Fertil Branch, Div Reprod Hlth, NCCDPHP, Atlanta, GA 30333 USA
关键词
SAFETY; IMMUNIZATION; STILLBIRTH; OUTCOMES; IMPACT; BIRTH;
D O I
10.1007/s40264-016-0482-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction Routine immunization of pregnant women with seasonal inactivated influenza vaccines (IIVs) is recommended in all trimesters of pregnancy. A review of the Vaccine Adverse Event Reporting System (VAERS) during 1990-2009 did not find any unexpected patterns of pregnancy complications or fetal outcomes after administration of IIV or live attenuated influenza vaccines (LAIVs). During the 2009-2010 pandemic influenza A (H1N1) vaccination campaign, a study noted that the number of VAERS reports from pregnant women who received the H1N1 2009 inactivated monovalent vaccine (n = 288) increased compared with 1990-2009 seasonal IIV pregnancy reports (n = 148). Objectives The objective of this study was to assess the safety of seasonal influenza vaccines in pregnant women and their infants whose reports were submitted to VAERS during 2010-2016. Methods We searched VAERS for US reports of adverse events (AEs) in pregnant women who received IIV or LAIV from 1 July 2010 through 6 May 2016. Clinicians reviewed reports and available medical records and assigned a primary clinical category for each report. Reports were coded as serious based on the Code of Federal Regulations. Results We identified 671 reports after seasonal influenza vaccines administered to pregnant women: 544 after IIV and 127 after LAIV. Serious events occurred among 61 (11.2%) reports following IIV and one (0.8%) report following LAIV. No deaths were reported. Among reports with trimester information (n = 296), IIV was administered during the first trimester in 116 (39.2%). Among IIV reports, the most frequent pregnancy-specific AE was spontaneous abortion in 62 (11.4%) reports, followed by stillbirth in ten (1.8%) and preterm delivery in six (1.1%). The most common non-pregnancy-specific AEs were injection-site reactions (55 [10.1%]). Neonatal or infant outcomes were reported in 22 (4.0%) reports, seven of which had major birth defects of different types and no neonatal deaths. Conclusion As in 2009-2010, no new or unexpected patterns in maternal or fetal outcomes were observed during 2010-2016.
引用
收藏
页码:145 / 152
页数:8
相关论文
共 50 条
  • [1] Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010–May 2016
    Pedro Moro
    Jane Baumblatt
    Paige Lewis
    Janet Cragan
    Naomi Tepper
    Maria Cano
    [J]. Drug Safety, 2017, 40 : 145 - 152
  • [2] MYOPATHY AFTER INFLUENZA VACCINATION: REPORTS TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM
    Thepmankorn, Parisorn
    Jedidi, Nour
    Souayah, Sami
    Nasar, Abu
    Souayah, Nizar
    [J]. MUSCLE & NERVE, 2021, 64 : S12 - S12
  • [3] Adverse Events Following Trivalent Inactivated Influenza Vaccination in Children Analysis of the Vaccine Adverse Event Reporting System
    Muhammad, Riyadh D.
    Haber, Penina
    Broder, Karen R.
    Leroy, Zanie
    Ball, Robert
    Braun, M. Miles
    Davis, Robert L.
    McMahon, Ann W.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (01) : E1 - E8
  • [4] Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009
    Moro, Pedro L.
    Broder, Karen
    Zheteyeva, Yenlik
    Walton, Kimp
    Rohan, Patricia
    Sutherland, Andrea
    Guh, Alice
    Haber, Penina
    DeStefano, Frank
    Vellozzi, Claudia
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (02) : 146.e1 - 146.e7
  • [5] Clinical Patterns of Adverse Events after High-Dose Influenza Vaccine Reported to the Vaccine Adverse Event Reporting System
    Moro, Pedro L.
    Arana, Jorge
    Cano, Maria
    Lewis, Paige
    Haber, Penina
    Menschik, David
    Martin, David
    Broder, Karen
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S362 - S362
  • [6] Safety of seasonal influenza vaccines in pregnancy in the vaccine adverse event reporting system, 2010-2014
    Moro, Pedro L.
    Lewis, Paige
    Cragan, Janet
    Tepper, Naomi
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 180 - 181
  • [7] Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016
    Su, John R.
    Moro, Pedro L.
    Ng, Carmen S.
    Lewis, Paige W.
    Said, Maria A.
    Cano, Maria V.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (04) : 1465 - 1473
  • [8] Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System
    Moro, Pedro L.
    Broder, Karen
    Zheteyeva, Yenlik
    Revzina, Natalya
    Tepper, Naomi
    Kissin, Dmitry
    Barash, Faith
    Arana, Jorge
    Brantley, Mary D.
    Ding, Helen
    Singleton, James A.
    Walton, Kimp
    Haber, Penina
    Lewis, Paige
    Yue, Xin
    DeStefano, Frank
    Vellozzi, Claudia
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 205 (05) : 473.e1 - 473.e9
  • [9] Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007
    Niu, Manette T.
    Ball, Robert
    Woo, Emily Jane
    Burwen, Dale R.
    Knippen, Maureen
    Braun, M. Miles
    [J]. VACCINE, 2009, 27 (02) : 290 - 297
  • [10] Postlicensure Safety Surveillance for High-Dose Trivalent Inactivated Influenza Vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010
    Moro, Pedro L.
    Arana, Jorge
    Cano, Maria
    Menschik, David
    Yue, Xin
    Lewis, Paige
    Haber, Penina
    Martin, David
    Broder, Karen
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 54 (11) : 1608 - 1614